Glazer Capital LLC’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Glazer Capital LLC’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300	Closed	-$3K	–	395
2023 Q1	$3K	Hold	300	–	–	﹤0.01%	326
2022 Q4	$3K	Buy	+300	New	+$3.03K	﹤0.01%	484
2022 Q1	–	Sell	-32,154	Closed	-$323K	–	1070
2021 Q4	$323K	Buy	+32,154	New	+$325K	0.01%	538

Glazer Capital LLC's LVACU Position: Q2 2023 in Review

Glazer Capital LLC sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q2 2023, closing a stake of 300 shares — an estimated $3K sold.

Glazer Capital LLC first reported a position in LVACU in Q4 2021 and held it in 3 quarters. The position peaked at $323K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACU as of Q2 2023.

Glazer Capital LLC reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Glazer Capital LLC sold 300 LAVA Medtech Acquisition Corp. Unit shares in Q2 2023, an estimated $3K.
Glazer Capital LLC first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
Glazer Capital LLC's LAVA Medtech Acquisition Corp. Unit position peaked at $323K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q2 2023.

Based on Glazer Capital LLC's 13F filing for Q2 2023, filed 14 Aug 2023.